FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Pre-submission and Q-Submission meetings apparently have been halted, for now
For clinical labs, the proposed law could bring more consistency to test ordering
The US Supreme Court decision that recently overturned the Chevron doctrine is influencing potential enactment of new legislation
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
How the MolDX® program works, what it covers, and how it can support better test access, use, and reimbursement in the clinical lab
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Three main risks to consider when it comes to personal electronic devices, and how to safely incorporate their use in the laboratory
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
A lawsuit by a group of herring fishermen upended 40 years of legal precedent regarding how federal agencies interpret statutes
How virtual reality technologies can support clinical laboratory education efforts and what leaders should know about implementation
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.